Sales of medical properties in the first half 2023 were $3.1 billion, off by two-thirds of 2022’s hot first half volume of $9.2 billion. Last year’s strong start was buoyed by the last dash of large portfolio trades closed early in the year, before interest rates started their rapid climb. Juxtaposed to other major property …
First Half 2023 Medical Office Sales Dip but Show Reason for Optimism Read More »
You are unauthorized to view this page. Username Password Remember Me Forgot Password
You are unauthorized to view this page.
Amulti-tenant medical office building near Milford Hospital has sold for nearly $1 million. The property at 140 Clark St., was bought for $965,000 by 140Clark LLP from Wallbanger Enterprises LLC in a deal recorded Aug. 14. The two-story building has multiple tenants, including several medical professional suites. Read the full article: Medical Office Building near …
Medical Office Building near Milford Hospital Trades Hands for Nearly $1M Read More »
You are unauthorized to view this page.
Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of three newly built properties for $5.2 million. The portfolio spans three brands: Aspen Dental, Starbucks, and WellNow Urgent Care. Read …
FCPT Announces Acquisition of a Three Property Developer Portfolio for $5.2M Read More »
You are unauthorized to view this page.
CareTrust REIT, Inc. (NYSE:CTRE) announces that it has completed a joint venture investment to acquire La Fuente Post Acute, a 187-bed skilled nursing facility located in Vista, California. Once regulatory approval is obtained, the facility will be operated by Bayshire Senior Communities (a current tenant of CareTrust) pursuant to a new 15-year lease with the …
Biocon’s step-down, wholly owned subsidiary, Biocon Generics, has purchased the US-based oral solid dosage manufacturing facility of Eywa Pharma for a total consideration of $7.7m (Rs636.77m). Located in Cranbury, New Jersey, the facility boasts the potential for a capacity expansion of up to two billion tablets or capsules annually. The facility’s existing personnel will move …
Biocon Generics Purchases Eywa’s Manufacturing Facility in US Read More »
You are unauthorized to view this page.
